Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2022 | 2 |
2024 | 2 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia.
J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3241-e3253. doi: 10.1210/clinem/dgac296.
J Clin Endocrinol Metab. 2022.
PMID: 35533340
Free PMC article.
Clinical Trial.
Bone Matrix Mineralization and Response to Burosumab in Adult Patients With X-Linked Hypophosphatemia: Results From the Phase 3, Single-Arm International Trial.
Fratzl-Zelman N, Hartmann MA, Gamsjaeger S, Rokidi S, Paschalis EP, Blouin S, Zwerina J.
Fratzl-Zelman N, et al.
J Bone Miner Res. 2022 Sep;37(9):1665-1678. doi: 10.1002/jbmr.4641. Epub 2022 Aug 10.
J Bone Miner Res. 2022.
PMID: 35775373
Free article.
Clinical Trial.
Item in Clipboard
Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial.
Insogna KL, Rauch F, Kamenický P, Ito N, Kubota T, Nakamura A, Zhang L, Mealiffe M, San Martin J, Portale AA.
Insogna KL, et al.
J Bone Miner Res. 2019 Dec;34(12):2183-2191. doi: 10.1002/jbmr.3843. Epub 2019 Oct 1.
J Bone Miner Res. 2019.
PMID: 31369697
Free PMC article.
Clinical Trial.
Item in Clipboard
Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia Estimated by Oral D-[6,6-2H2]-glucose.
Rossi A, Oosterveer MH, van Dijk TH, Bleeker A, Koehorst M, Weinstein DA, Bakker BM, Derks TGJ.
Rossi A, et al.
J Clin Endocrinol Metab. 2024 Jan 18;109(2):389-401. doi: 10.1210/clinem/dgad537.
J Clin Endocrinol Metab. 2024.
PMID: 37690115
Free PMC article.
Item in Clipboard
Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study.
De Giorgis V, Bhatia KP, Boespflug-Tanguy O, Gras D, Marina AD, Desurkar A, Toledo M, Miller I, Rotstein M, Schneider SA, Tarquinio DC, Weber Y, Brandabur M, Mayhew J, Koutsoukos T, De Vivo DC.
De Giorgis V, et al.
Mov Disord. 2024 May 9. doi: 10.1002/mds.29822. Online ahead of print.
Mov Disord. 2024.
PMID: 38725190
Item in Clipboard
Cite
Cite